［1］ Yamagata M, Sanes J R, Weiner J A. Synaptic adhesion molecules［J］. Curr Opin Cell Biol, 2003, 15(5):621-632．
［2］ Linger R M, Keating A K, Earp H S, et al. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer［J］．Adv Cancer Res, 2008, 100:35-83．
［3］ Avilla E, Guarino V, Visciano C, et al. Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer［J］. Cancer Research, 2011, 71(5):1792-1804.
［4］ Song X Z, Wang H, Logsdon C D, et al. Overexpression of Receptor Tyrosine Kinase Axl Promotes Tumor Cell Invasion and Survival in Pancreatic Ductal Adenocarcinoma［J］. Cancer, 2011, 117(4):734-743.
［5］ Ou W B, Corson J M, Flynn D L, et al. AXL regulates mesothelioma proliferation and invasiveness［J］. Oncogene, 2011, 30(14):1643-1652.
［6］ Melaragno M G, Cavet M E, Yan C, et al. Gas6 inhibits apoptosis in vascular smooth muscle：role of Axl kinase and Akt［J］. J Mol Cell Cardiol, 2004, 37:881-887.
［7］ Holland S J, Powell M J, Franci C, et al. Multiple roles for the receptor tyrosine kinase axl in tumor formation［J］．Cancer Res, 2005, 65(20):9294-9303.
［8］ Zhang Y X, Knyazev P G, Cheburkin Y V, et al. AXL is a potential target for therapeutic intervention in breast cancer progression［J］. Cancer Research, 2008, 68(6):1905-1915.
［9］ Shieh Y S, Lai C Y, Kao Y R, et al. Expression of Axl in lung adenocarcinoma and correlation with tumor progression［J］. Neoplasia, 2005, 7(12):1058-1064.
［10］ Tai K Y, Shieh Y S, Lee C S, et al. Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappa B and Brg-1［J］. Oncogene, 2008, 27(29):4044-4055.
［11］ Christine Gjerdrum, Crina Tiron, Torill Hoiby, et al. Axl is an essential epithelial-to -mesenchymal transition-induced regulator of breast cancer metastasis and patient survival［J］. Cell Biology, 2010, 107(3):1124-1129.
［12］ Alvarez H, Montgomery E A, Karikari C, et al. The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma［J］. Cancer Biology & Therapy, 2010, 10:l009-1018.
［13］ Sawabu T, Seno H, Kawashima T, et al. Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway［J］. Molecular Carcinogenesis, 2007, 46(2):155-164.
［14］ Mudduluru Giridhar, Vajkoczy P, Allgayer H. Myeloid Zinc Finger 1 Induces Migration, Invasion, and In vivo Metastasis through Axl Gene Expression in Solid Cancer［J］. Molecular Cancer Research, 2010, 8(2):159-169.
［15］ Koorstra JBM, Karikari C A, Feldmann G, et al. The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target［J］. Cancer Biology & Therapy, 2009, 8(7):618-626.
［16］ Mollard A, Warner S L, Call L T, et al. Design, Synthesis, and Biological Evaluation of a Series of Novel AXL Kinase Inhibitors［J］. ACS Medicinal Chemistry Letters, 2011，2(12):907-912.
［17］ Xu M Z, Chan S W, Liu A M, et al. AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma［J］. Oncogene，2011，30(10):1229-1240.
［18］ He L, Zhang J N, Jiang, L L, et al. Differential Expression of Axl in Hepatocellular Carcinoma and Correlation With Tumor Lymphatic Metastasis［J］. Molecular Carcinogenesis, 2010, 49(10): 882-891.
［19］ Holland S J, Pan A, Franci C, et al. R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer［J］. Cancer Research, 2010, 70(4):1544-1554.
［20］ Liu L, Greger J, Shi H, et al. Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL［J］. Cancer Research, 2009, 69(17):6871-6878.
［21］ Mahadevan D, Cooke L, Riley C, et al. A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors［J］. Oncogene, 2007, 26(27):3909-3919．
(2012-10-25